Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Concord Healthcare Group CoHKSE:02453 -5.63%30 PS Ratio is 0.99 as of Jul. 29, 2026, which is 92% below its 10-year median of 12.04. GuruFocus rates HKSE:02453 with a GF Score™ of 30/100. The stock has 6 warning signs investors should review. Among 658 Healthcare Providers & Services companies, Concord Healthcare Group Co ranks better than 63.68% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Concord Healthcare Group Co's share price is HK$0.67.
Concord Healthcare Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.67. Hence, Concord Healthcare Group Co's PS Ratio for today is 0.99.
Good Sign:
Concord Healthcare Group Co Ltd stock PS Ratio (=1.06) is close to 3-year low of 1.03.
The historical rank and industry rank for Concord Healthcare Group Co's PS Ratio or its related term are showing as below:
HKSE:02453'
s PS Ratio Range Over the Past 10 Years
Min: 1 Med: 12.04 Max: 66.18
Current: 1
During the past 6 years, Concord Healthcare Group Co's highest PS Ratio was 66.18. The lowest was 1.00. And the median was 12.04.
HKSE:02453's PS Ratio is ranked better than 63.68% of 658
companies
in the Healthcare Providers & Services industry
Industry Median: 1.5
vs HKSE:02453: 1.00
During the past 6 years, Concord Healthcare Group Co's highest 3-Year average Revenue per Share Growth Rate was 44.00% per year. The lowest was -10.40% per year. And the median was -2.70% per year.
Back to Basics: PS Ratio
Concord Healthcare Group Co (HKSE:02453) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Concord Healthcare Group Co PS Ratio Related Terms
Concord Healthcare Group Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Concord Healthcare Group Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Concord Healthcare Group Co PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Concord Healthcare Group Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Concord Healthcare Group Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Concord Healthcare Group Co's Share Price of today is HK$0.67.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Concord Healthcare Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.67.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Concord Healthcare Group Co (HKSE:02453) has a PS Ratio of 0.99 as of Jul. 29, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Concord Healthcare Group Co and its competitors. This is 92% below median its historical median of 12.04. Over the past decade, Concord Healthcare Group Co's PS Ratio has ranged from 1.00 to 66.18. According to the industry distribution chart, Concord Healthcare Group Co ranks #239 out of 658 companies in the Healthcare Providers & Services industry, placing it in the top 36.3%.
Is Concord Healthcare Group Co's PS Ratio too high?
Concord Healthcare Group Co's current PS Ratio of 0.99 is 92% below median its 10-year median of 12.04. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 66.18. The Healthcare Providers & Services industry median PS Ratio is 1.50. Concord Healthcare Group Co's value of 0.99 is 34% below this industry median. Based on the distribution chart, Concord Healthcare Group Co ranks #239 out of 658 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Concord Healthcare Group Co has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Concord Healthcare Group Co's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Concord Healthcare Group Co ranks #239 out of 658 companies for PS Ratio. This puts Concord Healthcare Group Co in the upper half of its industry. The industry median PS Ratio is 1.50. Concord Healthcare Group Co's value of 0.99 is 34% below this benchmark. Historically, Concord Healthcare Group Co's own PS Ratio has ranged from 1.00 to 66.18 over the past decade. While the company's 10-year median is 12.04 vs. the industry median of 1.50, Concord Healthcare Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.50, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Concord Healthcare Group Co's current PS Ratio of 0.99 is 34% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Concord Healthcare Group Co and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Concord Healthcare Group Co's current PS Ratio is 0.99, which is 92% below median its own 10-year median of 12.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Healthcare Group Co stock overvalued right now?
Concord Healthcare Group Co (HKSE:02453) has a current PS Ratio of 0.99. The current PS Ratio is 0.99, which is 92% below median its 10-year median of 12.04 and 34% below the Healthcare Providers & Services industry median of 1.50. Concord Healthcare Group Co's overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Concord Healthcare Group Co (HKSE:02453), the current PS Ratio is 0.99 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The Group owns and operates four offline self-operated medical institutions and one medical institution under construction, dedicated to providing comprehensive and specialized medical services to cancer patients. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is generated from its hospital business and its medical equipment, software, and related services segment. Substantially all of the company's revenue is generated from the PRC.
30GF Score
Get the complete analysis for HKSE:02453
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02453 has been successfully added to your 
